Topic: pharmacy benefit management
Rebates for Part D drugs grew from 2011 to 2015 but not enough to offset price spikes, a study found.
Surescripts has terminated its contract with ReMy Health based on new allegations about the startup's fraudulent behavior.
Cigna is launching a new solution as part of its health services business aimed at mitigating the high cost of emerging gene therapy treatments.
Capital Rx announced Wednesday the formal launch of its “Clearinghouse Model,” the startup's new approach aimed at greater transparency.
CVS Caremark is seeing savings on drug costs by nixing specific products with high inflation off formularies.
A judge granted a preliminary injunction to block the executive who ran CVS' Caremark retail network from joining Amazon's PillPack.
The country's biggest health insurers raked in more than $11 billion in profit in the second quarter.
A spat between CVS Caremark and a birth control subscription service led to a social media firestorm, with calls to #BoycottCVS trending on Twitter.
Canadian officials got an earful from the healthcare industry over the U.S. proposal to import drugs from the country.
Cigna saw its pharmacy services business increase by $23 billion after taking on PBM Express Scripts in a merger last year.